Changes after publication

Changes after publication

February 2014: implementation section updated to clarify that febuxostat is recommended as an option for the management of hyperuricaemia in people with gout. Additional minor maintenance update also carried out.

March 2012: minor maintenance

  • National Institute for Health and Care Excellence (NICE)